PMID- 35362254 OWN - NLM STAT- Publisher LR - 20240220 IS - 1096-9888 (Electronic) IS - 1076-5174 (Print) IS - 1076-5174 (Linking) VI - 57 IP - 4 DP - 2022 Mar 14 TI - A mass spectrometry-based non-radioactive differential radial capillary action of ligand assay (DRaCALA) to assess ligand binding to proteins. PG - e4822 LID - 10.1002/jms.4822 [doi] LID - e4822 AB - Binding of ligands to macromolecules changes their physicochemical and enzymatic characteristics. Cyclic di-GMP is a second messenger involved in motility/sessility and acute/chronic infection life style transition. Although the GGDEF domain, predominantly a diguanylate cyclase, represents one of the most abundant bacterial domain superfamilies, the number of cyclic di-GMP receptors falls short. To facilitate screening for cyclic di-nucleotide binding proteins, we describe a non-radioactive, matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF)-based modification of the widely applied differential radial capillary action of ligand assay (DRaCALA). The results of this assay suggest that the diguanylate cyclase/phosphodiesterase variant YciR(Fec101) , but not selected catalytic mutants, bind cyclic di-GMP. HIGHLIGHTS: Cyclic di-nucleotides are ubiquitous second messengers in bacteria. However, few receptors have been identified. Previous screening of cell lysates by differential radial capillary action of ligand assay (DRaCALA) using radioactive ligand identified cyclic di-nucleotide binding proteins. A MALDI-TOF-based DRaCALA was developed to detect cyclic di-nucleotide binding as a non-radioactive alternative. Known cyclic di-GMP binding proteins were verified and potential cyclic di-GMP binding proteins were identified. CI - (c) 2022 The Authors. Journal of Mass Spectrometry published by John Wiley & Sons Ltd. FAU - Cimdins-Ahne, Annika AU - Cimdins-Ahne A AUID- ORCID: 0000-0001-7414-9914 AD - Department of Microbiology, Tumor and Cell Biology, Biomedicum, Karolinska Institutet, Solna, Sweden. FAU - Chernobrovkin, Alexey AU - Chernobrovkin A AD - Department of Medical Biochemistry and Biophysics, Biomedicum, Karolinska Institutet, Solna, Sweden. AD - Pelago Bioscience AB, Solna, Sweden. FAU - Kim, Soo-Kyoung AU - Kim SK AD - Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, USA. FAU - Lee, Vincent T AU - Lee VT AUID- ORCID: 0000-0002-3593-0318 AD - Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, USA. FAU - Zubarev, Roman A AU - Zubarev RA AUID- ORCID: 0000-0001-9839-2089 AD - Department of Medical Biochemistry and Biophysics, Biomedicum, Karolinska Institutet, Solna, Sweden. AD - Department of Pharmacological and Technological Chemistry, I.M. Sechenov First Moscow State Medical University, Moscow, Russia. FAU - Romling, Ute AU - Romling U AUID- ORCID: 0000-0003-3812-6621 AD - Department of Microbiology, Tumor and Cell Biology, Biomedicum, Karolinska Institutet, Solna, Sweden. LA - eng GR - Karolinska Institutet/ GR - 621-2013-4809/Swedish Research Council for Natural Sciences and Engineering/ GR - CI 239/1-1/Deutsche Forschungsgemeinschaft/ GR - CI 239/2-1/Deutsche Forschungsgemeinschaft/ PT - Journal Article DEP - 20220314 PL - England TA - J Mass Spectrom JT - Journal of mass spectrometry : JMS JID - 9504818 SB - IM PMC - PMC9285882 OTO - NOTNLM OT - biofilm OT - cyclic di-GMP OT - diguanylate cyclase/phosphodiesterase OT - mass spectrometry OT - non-radioactive DRaCALA EDAT- 2022/04/02 06:00 MHDA- 2022/04/02 06:00 PMCR- 2022/07/15 CRDT- 2022/04/01 05:40 PHST- 2022/02/13 00:00 [received] PHST- 2022/03/07 00:00 [accepted] PHST- 2022/04/01 05:40 [entrez] PHST- 2022/04/02 06:00 [pubmed] PHST- 2022/04/02 06:00 [medline] PHST- 2022/07/15 00:00 [pmc-release] AID - JMS4822 [pii] AID - 10.1002/jms.4822 [doi] PST - aheadofprint SO - J Mass Spectrom. 2022 Mar 14;57(4):e4822. doi: 10.1002/jms.4822.